Subscribe to RSS
DOI: 10.1055/a-2661-4287
Perinatal Outcomes in Pregnancies Immediately following Stillbirth: A Multicenter, Prospective, Observational Study
Funding None.

Abstract
Objective
This study aimed to evaluate the outcomes of pregnancies immediately following stillbirth in relation to treatments prescribed.
Study Design
A prospective, observational study was conducted in patients with a history of stillbirth (≥22 weeks) between 2014 and 2022 across four Italian University Hospitals. Outcomes were stratified based on the cause of previous fetal death (classified according to ReCoDe classification) and treatment (low dose aspirin [LDA], low molecular weight heparin [LMWH], both, progesterone, or other drugs). The main outcome was adverse neonatal outcome, including perinatal death, stillbirth recurrence, intrauterine growth restriction, early preterm birth, Apgar < 7 at 5 minutes, and need for neonatal resuscitation. The secondary outcome was adverse maternal outcome, including postpartum hemorrhage, emergency cesarean delivery, and operative vaginal delivery.
Results
Among 308 subsequent pregnancies, 46 (14.94%) had an adverse neonatal outcome, including 4 stillbirths. A total of 76 pregnancies (24.68%) experienced adverse maternal outcome, and 19 pregnancies (6.17%) had both. In individuals with previous placental vascular disorders (PVDs), adverse neonatal outcomes were reduced by 75% when treated with LDA + LMWH (odds ratio [OR]: 0.25; 95% confidence interval [CI]: 0.06–1.03; p = 0.049). However, adverse maternal outcome was significantly higher in individuals who received LDA + LMWH without specific indications (OR: 3.07; 95% CI: 1.07–8.78; p = 0.036).
Conclusion
LDA and LMWH should be prescribed only for previous PVDs to improve adverse neonatal outcome and avoid unnecessary maternal risk.
Key Points
-
LDA + LMWH reduces neonatal risk after placental stillbirths.
-
Unnecessary LDA + LMWH increases maternal complications.
-
Prescribe LDA + LMWH only with placental indications.
Declaration of GenAI Use
During the writing process of this paper, the author(s) used ChatGPT-4 in order to improve readability and language of the work. The author(s) reviewed and edited the text and take(s) full responsibility for the content of the paper.
Publication History
Received: 16 May 2025
Accepted: 21 July 2025
Accepted Manuscript online:
22 July 2025
Article published online:
07 August 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Vander Haar EL, Wu G, Gyamfi-Bannerman C. et al. Microbial analysis of umbilical cord blood reveals novel pathogens associated with stillbirth and early preterm birth. MBio 2022; 13 (05) e0203622
- 2 Clemenza S, Serena C, Vannuccini S. et al. Pregnancy outcomes subsequent to stillbirth—a single tertiary-care center experience. Clin Exp Obstet Gynecol 2022; 49 (11) 247
- 3 Silver RM, Stone JL. A United States stillbirth prevention bundle. Am J Obstet Gynecol 2024; 231 (02) 147-149
- 4 EURO-PERISTAT Project. European Perinatal Health Report: Core Indicators of the Health and Care of Pregnant Women and Babies in Europe (2015–2019) [Internet]. 2022 . Accessed February 16, 2025 at: https://www.europeristat.com/wp-content/uploads/2022/11/Euro-Peristat_Fact_sheets_2022_for_upload.pdf
- 5 Bhattacharya S, Prescott GJ, Black M, Shetty A. Recurrence risk of stillbirth in a second pregnancy. BJOG 2010; 117 (10) 1243-1247
- 6 Di Tommaso M, Vannacci A, Mecacci F. et al. Gestione della morte endouterina fetale (MEF). Prendersi cura della natimortalità. Fondazione Confalonieri Ragonese; 2023 . Accessed February 16, 2025 at: https://www.aogoi.it/media/8827/17-raccomandazioni-mef-definitiva-7-febbraio-2023-min.pdf
- 7 Wojcieszek AM, Boyle FM, Belizán JM. et al. Care in subsequent pregnancies following stillbirth: an international survey of parents. BJOG 2018; 125 (02) 193-201
- 8 Management of Stillbirth: Obstetric Care Consensus No, 10. Obstet Gynecol 2023; 141 (05) 1030
- 9 Management of Stillbirth: Obstetric Care Consensus No, 10. Obstet Gynecol 2020; 135 (03) e110-e132
- 10 Burden C, Merriel A, Bakhbakhi D, Heazell A, Siassakos D. Royal College of Obstetricians and Gynaecologists. Care of late intrauterine fetal death and stillbirth: Green-top Guideline No. 55. BJOG 2025; 132 (01) e1-e41
- 11 Zupan J, Åhman E. . Neonatal and perinatal mortality: Country, regional and global estimates. Geneva: World Health Organization; 2006 :69. Accessed February 16, 2025 at: https://iris.who.int/bitstream/handle/10665/43444/9241563206_eng.pdf?sequence=1
- 12 Gardosi J, Kady SM, McGeown P, Francis A, Tonks A. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 2005; 331 (7525) 1113-1117
- 13 Institute of Medicine National Research Council Committee to Reexamine I. O. M. Pregnancy Weight Guidelines. The national academies collection: reports funded by national institutes of health. In: Rasmussen KM, Yaktine AL, editors. Weight gain during pregnancy: reexamining the guideline. Washington (DC): National Academies Press (US), National Academy of Sciences; 2009
- 14 Salerno C, Melis B, Donno V. et al. Risk factors for stillbirth at term: an Italian area-based, prospective cohort study. AJOG Glob Rep 2023; 3 (04) 100269
- 15 Monari F, Pedrielli G, Vergani P. et al. Adverse perinatal outcome in subsequent pregnancy after stillbirth by placental vascular disorders. PLoS One 2016; 11 (05) e0155761
- 16 Black M, Shetty A, Bhattacharya S. Obstetric outcomes subsequent to intrauterine death in the first pregnancy. BJOG 2008; 115 (02) 269-274
- 17 Bertino E, Spada E, Occhi L. et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr 2010; 51 (03) 353-361
- 18 Damhuis SE, Ganzevoort W, Gordijn SJ. Abnormal fetal growth: small for gestational age, fetal growth restriction, large for gestational age: definitions and epidemiology. Obstet Gynecol Clin North Am 2021; 48 (02) 267-279
- 19 Ofir K, Kalter A, Moran O, Sivan E, Schiff E, Simchen MJ. Subsequent pregnancy after stillbirth: obstetrical and medical risks. J Perinat Med 2013; 41 (05) 543-548
- 20 Lamont K, Scott NW, Jones GT, Bhattacharya S. Risk of recurrent stillbirth: systematic review and meta-analysis. BMJ 2015; 350: h3080
- 21 Po' G, Monari F, Zanni F, Grandi G, Lupi C, Facchinetti F. Stillbirth Emilia-Romagna Audit Group. A regional audit system for stillbirth: a way to better understand the phenomenon. BMC Pregnancy Childbirth 2019; 19 (01) 276
- 22 American Society for Reproductive Medicine, American College of Obstetricians and Gynecologists' Committee on Gynecologic Practice. Prepregnancy counseling: Committee Opinion No. 762. Fertil Steril 2019; 111 (01) 32-42
- 23 Ramji N, Corsi DJ, Gad M. et al. The impact of isolated obesity compared with obesity and other risk factors on risk of stillbirth: a retrospective cohort study. CMAJ 2024; 196 (08) E250-E259
- 24 Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ 2013; 346: f108
- 25 Flenady V, Koopmans L, Middleton P. et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011; 377 (9774) 1331-1340
- 26 Andrews CJ, Ellwood D, Middleton PF. et al; Safer Baby Bundle collaborators. Implementation and evaluation of a quality improvement initiative to reduce late gestation stillbirths in Australia: Safer Baby Bundle study protocol. BMC Pregnancy Childbirth 2020; 20 (01) 694
- 27 Pandey S, Shetty A, Hamilton M, Bhattacharya S, Maheshwari A. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Reprod Update 2012; 18 (05) 485-503
- 28 Wojcieszek AM, Shepherd E, Middleton P. et al. Care prior to and during subsequent pregnancies following stillbirth for improving outcomes. Cochrane Database Syst Rev 2018; 12 (12) CD012203
- 29 Chen J, Huai J, Yang H. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2024; 24 (01) 68
- 30 Cruz-Lemini M, Vázquez JC, Ullmo J, Llurba E. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis. Am J Obstet Gynecol 2022; 226 (2S): S1126-S1144 , 1144.e17
- 31 Reddy UM. Prediction and prevention of recurrent stillbirth. Obstet Gynecol 2007; 110 (05) 1151-1164